U.K. Criticizes Deliberations Over WHA Resolution On Drug Pricing Transparency, Disassociates From Agreement
The Telegraph: U.K. fails to back international agreement on reducing drug costs
“The U.K. has been accused of acting in bad faith after backing away from an international agreement aimed at reducing the cost of drugs worldwide. … In a statement to the WHA Julian Braithwaite, the U.K.’s ambassador to the United Nations in Geneva, said the government was committed to improving access to medicines. But he added: ‘The decision to bring this resolution to this World Health Assembly without first giving member states … the opportunity to review and input, in addition to the manner in which negotiations were conducted in the room, has not reflected the spirit of collaborative or consensus working that we should expect from this forum’…” (Gulland, 5/29).